Particle News: Latest European Medicines Agency news

EMA Rejects Eli Lilly's Alzheimer's Drug Kisunla Over Safety Concerns

The European Medicines Agency cited risks of brain swelling and bleeding, but Eli Lilly plans to seek a re-examination of the decision.

EU Drug Agency Recommends Approval of First Alzheimer’s Treatment Targeting Disease Progression

EMA Approves Lecanemab for Early-Stage Alzheimer’s Treatment in EU

Pfizer Withdraws Sickle Cell Drug Oxbryta Over Safety Concerns

EU Regulator Denies Approval for Alzheimer's Drug Lecanemab

EU and U.S. Health Agencies Confirm No Link Between Semaglutide and Suicidal Thoughts

EU Regulators Clear Ozempic and Related Drugs of Suicidal Thoughts Link

Large Study Finds No Link Between Acetaminophen Use During Pregnancy and Neurodevelopmental Disorders

EMA Investigates Potential Suicidal Thoughts Risk in Weight-Loss Medicines

FDA Approves SpringWorks' Ogsiveo, First Treatment for Desmoid Tumors

Fake Ozempic Injections Hospitalize Several in Austria, Raising Counterfeit Drug Concerns Across Europe

EU Investigates Potential Link Between Popular Weight Loss Drugs Like Ozempic and Suicidal Thoughts